Pablo M. Rusjan

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 122 publications

Corrigendum to "Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms" [EBioMedicine (2026) Jul 10: 106339].

Corrigendum to "Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms" [EBioMedicine (2026) Jul 10: 106339].

Journal: EBioMedicine

Published: September 05, 2026

EXPRESS: Kinetic modeling of the Tropomyosin Receptor Kinases radioligand [18F]TRACK in human brain with high-resolution positron emission tomography.

EXPRESS: Kinetic modeling of the Tropomyosin Receptor Kinases radioligand [18F]TRACK in human brain with high-resolution positron emission tomography.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: June 19, 2026

Kinetic modeling of the tropomyosin receptor kinases radioligand [18F]TRACK in human brain with high-resolution positron emission tomography.

Kinetic modeling of the tropomyosin receptor kinases radioligand [18F]TRACK in human brain with high-resolution positron emission tomography.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: June 19, 2026

Correction: Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development.

Correction: Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development.

Journal: Translational psychiatry

Published: March 17, 2026

Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia.

Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia.

Journal: The European journal of neuroscience

Published: March 10, 2026

PET imaging of FAAH in chronic Cannabis users: longitudinal assessment during short-term abstinence.

PET imaging of FAAH in chronic Cannabis users: longitudinal assessment during short-term abstinence.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: January 29, 2026

Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms.

Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms.

Journal: EBioMedicine

Published: November 24, 2025

Stress and synaptic density in psychosis and clinical high risk: evidence from [18F]SynVesT-1 PET.

Stress and synaptic density in psychosis and clinical high risk: evidence from [18F]SynVesT-1 PET.

Journal: Translational psychiatry

Published: September 12, 2025

A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use.

A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use.

Journal: Drug and alcohol dependence reports

Published: May 30, 2025

Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development.

Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development.

Journal: Translational psychiatry

Published: May 23, 2025

Fatty acid amide hydrolase in major depressive episodes: A [11C]CURB positron emission tomography study.

Fatty acid amide hydrolase in major depressive episodes: A [11C]CURB positron emission tomography study.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: February 20, 2025

The Role of Fatty Acid Amide Hydrolase, a Key Regulatory Endocannabinoid Enzyme, in Domain-Specific Cognitive Performance in Psychosis.

The Role of Fatty Acid Amide Hydrolase, a Key Regulatory Endocannabinoid Enzyme, in Domain-Specific Cognitive Performance in Psychosis.

Journal: Schizophrenia bulletin

Published: December 27, 2024

Showing 1-12 of 122

Last Updated: 09/26/2026